Prothrombin has remarkable affinity for calcium oxalate crystals. It is pro
duced in renal tubular cells and is detected as a urinary form of prothromb
in F1. The aim of this basic study was (1) to isolate prothrombin mRNA from
normal human and rat kidneys; (2) to confirm expression level changes in s
tone-forming rat kidneys; and (3) to analyze the DNA sequence of renal prot
hrombin. The aim of the clinical investigation was to measure the serum lev
els of renal prothrombin in clinical cases of various urologic diseases. Th
e expression of prothrombin mRNA in human kidneys and male Wister rat: kidn
eys was investigated using reverse transcription-PCR, with prothrombin (F1,
F2, and thrombin) primers. Renal prothrombin levels were measured in the s
era of patients with renal cell carcinoma, renal transplant donors, patient
s with chronic renal failure, and renal transplant recipients, using an enz
yme-linked immunosorbent assay. Expression of cyclophilin as well as prothr
ombin mRNA could be detected. Prothrombin mRNA expression levels seemed to
be increased in stone-forming rats. The DNA sequence of renal prothrombin d
iffered from that of liver prothrombin at three points. Repeated measuremen
ts of renal prothrombin showed that values were high during the acute tubul
ar necrosis period and tended to decrease with the recovery of renal functi
on. Prothrombin mRNA expression could be confirmed in human and rat kidneys
, as well as in stone-forming rat kidneys. Serum concentration measurements
can be considered useful for assessment of recovery from acute tubular nec
rosis after renal transplantation and for diagnosis of acute rejection.